Suppr超能文献

移植候补维持性血液透析患者的体重指数和体重减轻与死亡率的关系。

Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.

机构信息

Harold Simmons Center for Chronic Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.

出版信息

Am J Transplant. 2011 Apr;11(4):725-36. doi: 10.1111/j.1600-6143.2011.03468.x.

Abstract

A body mass index (BMI) below morbid obesity range is often a requirement for kidney transplant wait-listing, but data linking BMI changes to mortality during the waitlist period are lacking. By linking the 6-year (7/2001-6/2007) national databases of a large dialysis organization and the Scientific Registry of Transplant Recipients, we identified 14 632 waitlisted hemodialysis patients without kidney transplantation. Time-dependent survival models examined the mortality predictability of 13-week-averaged BMI, pretransplant serum creatinine as a muscle mass surrogate and their changes over time. The patients were on average 52 ± 13 years old, 40% women and had a BMI of 26.9 ± 6.3 kg/m². Each kg/m² increase of BMI was associated with a death hazard ratio (HR) of 0.96 (95%CI: 0.95-0.97). Compared to the lowest creatinine quintile, the 4th and 5th quintiles had death HRs of 0.75 (0.66-0.86) and 0.57 (0.49-0.66), respectively. Compared to minimal (< ± 1 kg) weight change over 6 months, those with 3 kg- < 5 kg and ≥ 5 kg weight loss had death HRs of 1.31 (1.14-1.52) and 1.51 (1.30-1.75), respectively. Similar associations were observed with creatinine changes over time. Transplant-waitlisted hemodialysis patients with lower BMI or muscle mass and/or unintentional weight or muscle loss have higher mortality in this observational study. Impact of intentional weight change remains unclear.

摘要

身体质量指数(BMI)低于病态肥胖范围通常是肾移植候补名单的要求,但缺乏将 BMI 变化与候补期间死亡率相关联的数据。通过将大型透析组织的 6 年(2001 年 7 月-2007 年 6 月)国家数据库与移植受者科学登记处相链接,我们确定了 14632 名未接受肾移植的候补血液透析患者。时间依赖性生存模型检查了 13 周平均 BMI、移植前血清肌酐作为肌肉质量替代物及其随时间变化的死亡率预测能力。患者平均年龄为 52 ± 13 岁,40%为女性,BMI 为 26.9 ± 6.3kg/m²。BMI 每增加 1kg/m²,死亡风险比(HR)为 0.96(95%CI:0.95-0.97)。与肌酐最低五分位数相比,第 4 五分位数和第 5 五分位数的死亡 HR 分别为 0.75(0.66-0.86)和 0.57(0.49-0.66)。与 6 个月期间体重变化最小(<±1kg)相比,体重减轻 3kg-<5kg 和≥5kg 的死亡 HR 分别为 1.31(1.14-1.52)和 1.51(1.30-1.75)。随着时间的推移,肌酐变化也观察到类似的关联。在这项观察性研究中,BMI 或肌肉量较低且/或非故意体重或肌肉损失的移植候补血液透析患者死亡率较高。有意改变体重的影响仍不清楚。

相似文献

2
Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients.
Clin J Am Soc Nephrol. 2011 Jun;6(6):1463-73. doi: 10.2215/CJN.09131010. Epub 2011 Mar 17.
3
Trajectory of Lean Body Mass Assessed Using the Modified Creatinine Index and Mortality in Hemodialysis Patients.
Am J Kidney Dis. 2020 Feb;75(2):195-203. doi: 10.1053/j.ajkd.2019.05.034. Epub 2019 Sep 26.
4
[REIN Report 2011--summary].
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
5
A "weight-listing" paradox for candidates of renal transplantation?
Am J Transplant. 2007 Mar;7(3):550-9. doi: 10.1111/j.1600-6143.2006.01629.x. Epub 2006 Dec 6.
6
Survival in patients on hemodialysis: Effect of gender according to body mass index and creatinine.
PLoS One. 2018 May 16;13(5):e0196550. doi: 10.1371/journal.pone.0196550. eCollection 2018.
7
Association of body weight changes with mortality in incident hemodialysis patients.
Nephrol Dial Transplant. 2017 Sep 1;32(9):1549-1558. doi: 10.1093/ndt/gfw373.
9
Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients.
PLoS One. 2016 Mar 1;11(3):e0150003. doi: 10.1371/journal.pone.0150003. eCollection 2016.
10
Pre-Transplant Weight Loss and Survival after Kidney Transplantation.
Am J Nephrol. 2015;41(6):448-55. doi: 10.1159/000437341. Epub 2015 Jul 25.

引用本文的文献

1
Obesity measurement methods estimated mortality risk in patients undergoing hemodialysis: a systematic review and meta-analysis.
Int Urol Nephrol. 2025 May;57(5):1585-1600. doi: 10.1007/s11255-024-04312-1. Epub 2024 Dec 11.
2
Treatment of Type 2 Diabetes Mellitus in Advanced Chronic Kidney Disease for the Primary Care Physician.
Cureus. 2024 Jul 16;16(7):e64663. doi: 10.7759/cureus.64663. eCollection 2024 Jul.
3
Weight change in chronic kidney disease: Association with mortality and kidney function.
Obes Sci Pract. 2023 Nov 22;10(1):e723. doi: 10.1002/osp4.723. eCollection 2024 Feb.
4
Obesity is Associated With Delayed Graft Function in Kidney Transplant Recipients: A Paired Kidney Analysis.
Transpl Int. 2023 May 30;36:11107. doi: 10.3389/ti.2023.11107. eCollection 2023.
5
[Unintentional weight loss in chronic kidney disease].
Inn Med (Heidelb). 2023 Jun;64(6):532-539. doi: 10.1007/s00108-023-01527-9. Epub 2023 May 23.
6
Combined Donor-Recipient Obesity and the Risk of Graft Loss After Kidney Transplantation.
Transpl Int. 2022 Sep 29;35:10656. doi: 10.3389/ti.2022.10656. eCollection 2022.
7
Modifiable Lifestyle Behaviors and CKD Progression: A Narrative Review.
Kidney360. 2022 Jan 14;3(4):752-778. doi: 10.34067/KID.0003122021. eCollection 2022 Apr 28.
8
Obesity Management in Kidney Transplant Candidates: Current Paradigms and Gaps in Knowledge.
Adv Chronic Kidney Dis. 2021 Nov;28(6):528-541. doi: 10.1053/j.ackd.2021.09.009.
9
Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease.
Kidney Dial. 2022 Mar;2(1):106-122. doi: 10.3390/kidneydial2010013. Epub 2022 Mar 4.
10
Low muscle mass and early hospital readmission post-kidney transplantation.
Int Urol Nephrol. 2022 Aug;54(8):1977-1986. doi: 10.1007/s11255-021-03085-1. Epub 2022 Jan 14.

本文引用的文献

2
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients.
Clin J Am Soc Nephrol. 2010 Dec;5(12):2258-68. doi: 10.2215/CJN.02080310. Epub 2010 Oct 14.
3
Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis.
Am J Clin Nutr. 2010 Nov;92(5):1060-70. doi: 10.3945/ajcn.2010.29188. Epub 2010 Sep 15.
5
Kidney and pancreas transplantation in the United States, 1999-2008: the changing face of living donation.
Am J Transplant. 2010 Apr;10(4 Pt 2):987-1002. doi: 10.1111/j.1600-6143.2010.03022.x.
6
Pre-transplant overweight and obesity do not affect physical quality of life after kidney transplantation.
J Am Coll Surg. 2010 Mar;210(3):336-44. doi: 10.1016/j.jamcollsurg.2009.11.009. Epub 2010 Feb 1.
7
Association of hemodialysis treatment time and dose with mortality and the role of race and sex.
Am J Kidney Dis. 2010 Jan;55(1):100-12. doi: 10.1053/j.ajkd.2009.08.007. Epub 2009 Oct 22.
8
Obesity, surgical site infection, and outcome following renal transplantation.
Ann Surg. 2009 Dec;250(6):1014-20. doi: 10.1097/SLA.0b013e3181b4ee9a.
9
Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.
J Am Coll Cardiol. 2009 Apr 14;53(15):1265-72. doi: 10.1016/j.jacc.2008.12.040.
10
Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients.
Am J Kidney Dis. 2009 May;53(5):823-34. doi: 10.1053/j.ajkd.2008.12.040. Epub 2009 Apr 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验